Precision Biosensor, Inc. (KOSDAQ:335810)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,540.00
-14.00 (-0.90%)
At close: Aug 28, 2026

Precision Biosensor Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-7,874-10,023-7,305-4,490-6,806-4,152
Depreciation & Amortization
3,9193,9573,5903,1452,2821,179
Loss (Gain) From Sale of Assets
64.5116.05-3.01--5.27-
Asset Writedown & Restructuring Costs
1,9811,981----
Loss (Gain) From Sale of Investments
-9.02-2.42-33.36-90.06-137.79-48.66
Stock-Based Compensation
130.3611646.61155.26150.3373.59
Provision & Write-off of Bad Debts
18.9936.98-103.57241.11164.951.51
Other Operating Activities
2,5923,3832,624679.143,305527.58
Change in Accounts Receivable
-1,249-346.66403.1-342.54554.941,461
Change in Inventory
334.6415.86436.79108.1-1,940-2,421
Change in Accounts Payable
510.25254.72-34.56-385.38-276.4-947.73
Change in Other Net Operating Assets
-1,230-901.8-1,064-973.59132.85-246.8
Operating Cash Flow
-811.58-1,513-1,444-1,953-2,576-4,575
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-183.76-157.43-64.96-7,053-11,142-9,151
Sale (Purchase) of Intangibles
-4.9----3,785-25.8
Investment in Securities
-5,827-5,0005,534-2,90716,139-19,956
Other Investing Activities
40.9417.7107.7728.64-378.78-45.25
Investing Cash Flow
-4,229-4,8935,576-9,931142.17-29,178

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----285.08
Long-Term Debt Issued
--2,99414,9763,60016,882
Total Debt Issued
--2,99414,9763,60017,167
Long-Term Debt Repaid
--8,983-8,006-8,391-633.61-357.1
Total Debt Repaid
-9,834-8,983-8,006-8,391-633.61-357.1
Net Debt Issued (Repaid)
-9,834-8,983-5,0126,5852,96616,810
Issuance of Common Stock
16,97916,979-136.21,243635.31
Other Financing Activities
7.3722--0-0-0
Financing Cash Flow
6,9438,018-5,0126,7214,20917,445

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
71.79-44.72175.8432.37237.64-53.02
Net Cash Flow
1,9741,568-703.55-5,1302,013-16,361

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-995.33-1,670-1,509-9,006-13,719-13,726
Free Cash Flow Growth
------
Free Cash Flow Margin
-4.46%-8.38%-7.89%-44.17%-67.06%-86.40%
Free Cash Flow Per Share
-67.09-132.32-129.93-776.13-1190.18-1215.81
Levered Free Cash Flow
-3,904-2,139-11.76-10,697-11,321-14,441
Unlevered Free Cash Flow
-2,708-827.961,232-9,928-10,811-14,340

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
478.29483.68518.27428.63154.3517.46
Cash Income Tax Paid
9.8442.0817.43-78.9455.85-19.45
Change in Working Capital
-1,635-977.88-258.87-1,593-1,529-2,155